Latest Breaking News On - Himanshu gadgil - Page 4 : comparemela.com

Enzene Biosciences Ltd obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its third biosimilar drug 'Denosumab', indicated for the treatment of osteoporosis in adults.

United kingdomSouth koreaHimanshu gadgilEnzene teriparatideSandeep singhAscend laboratoriesAlkem laboratories ltdEnzene biosciences ltdEnzene biosciencesMarketing authorizationDrug controller generalWhole time directorManaging directorAlkem laboratoriesMarketing authorizationDrug controller general of india

Enzene Biosciences Ltd obtains a Marketing Authorization

Enzene Biosciences Ltd obtains a Marketing Authorization
singaporestar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from singaporestar.com Daily Mail and Mail on Sunday newspapers.

United kingdomSouth koreaHimanshu gadgilEnzene teriparatideSandeep singhAscend laboratoriesAlkem laboratories ltdEnzene biosciences ltdEnzene biosciencesMarketing authorizationDrug controller generalWhole time directorManaging directorAlkem laboratories

Enzene Biosciences Ltd obtains a Marketing Authorization

Enzene Biosciences Ltd obtains a Marketing Authorization
northkoreatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northkoreatimes.com Daily Mail and Mail on Sunday newspapers.

Enzene Biosciences Announced Romiplostim Approval in India | Goodwin

Enzene Biosciences Announced Romiplostim Approval in India | Goodwin
jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.

Himanshu gadgilEnzene romiplostimEnzene biosciencesAlkem laboratories ltdDrug controller generalImmune thrombocytopenic purpuraWhole time director

Enzene obtains marketing authorisation for Romiplostim Biosimilar drug in India

BioSpectrum is an integrated B2B media platform for the healthcare and bioscience industry in India and Asia.

Enzene romiplostimHimanshu gadgilEnzene biosciencesSandeep singhAlkem laboratoriesMarketing authorizationDrug controller generalImmune thrombocytopenic purpuraWhole time directorHealthcare managementLife sciencesUs healthcareAsia biotechஹிமான்ஷு காட்கில்சந்தீப் சிங்அல்கெம் ஆய்வகங்கள்